+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Resorbable Vascular Scaffold Market Research Report by Material Type (Metal Based BVS and Polymer Based BVS), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 241 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4985883
UP TO OFF until Dec 31st 2022
The Global Resorbable Vascular Scaffold Market size was estimated at USD 393.18 million in 2021, USD 446.29 million in 2022, and is projected to grow at a CAGR 13.68% to reach USD 848.75 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Resorbable Vascular Scaffold to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Material Type, the market was studied across Metal Based BVS and Polymer Based BVS.
  • Based on Application, the market was studied across Coronary Artery Stents and Peripheral Artery Stents.
  • Based on End User, the market was studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Resorbable Vascular Scaffold market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Resorbable Vascular Scaffold Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Resorbable Vascular Scaffold Market, including 480 Biomedical Inc, Abbott Laboratories, Amaranth Medical, Inc., AMG International, Arterial Remodeling Technologies, Biosensors International Group, Limited, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardionovum GmbH, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., LEPU medical technology co., ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., OrbusNeich, Qualimed, REVA Medical, Inc., S3V Vascular Technologies Private Limited, Stentys SA, and Svelte Medical Systems, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Resorbable Vascular Scaffold Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Resorbable Vascular Scaffold Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Resorbable Vascular Scaffold Market?
4. What is the competitive strategic window for opportunities in the Global Resorbable Vascular Scaffold Market?
5. What are the technology trends and regulatory frameworks in the Global Resorbable Vascular Scaffold Market?
6. What is the market share of the leading vendors in the Global Resorbable Vascular Scaffold Market?
7. What modes and strategic moves are considered suitable for entering the Global Resorbable Vascular Scaffold Market?
Frequently Asked Questions about the Global Resorbable Vascular Scaffold Market

What is the estimated value of the Global Resorbable Vascular Scaffold Market?

The Global Resorbable Vascular Scaffold Market was estimated to be valued at $393.18 Million in 2021.

What is the growth rate of the Global Resorbable Vascular Scaffold Market?

The growth rate of the Global Resorbable Vascular Scaffold Market is 13.6%, with an estimated value of $848.75 Million by 2027.

What is the forecasted size of the Global Resorbable Vascular Scaffold Market?

The Global Resorbable Vascular Scaffold Market is estimated to be worth $848.75 Million by 2027.

Who are the key companies in the Global Resorbable Vascular Scaffold Market?

Key companies in the Global Resorbable Vascular Scaffold Market include 480 Biomedical Inc, Abbott Laboratories, Amaranth Medical, Inc., AMG International, Arterial Remodeling Technologies, Biosensors International Group, Limited, Biotronik SE & Co. KG, Boston Scientific Corporation and Elixir Medical Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Risk of Cad and Pad in the Geriatric Population
5.1.1.2. Number of Clinical Trials and Development in Pipeline
5.1.1.3. Increasing Prevalence of Cardiovascular Diseases
5.1.2. Restraints
5.1.2.1. Presence of Alternative Methods
5.1.3. Opportunities
5.1.3.1. Growing Funding for R&D of Surgical Procedures
5.1.3.2. Inclination Towards Drug-Eluting Devices for Angioplasty
5.1.4. Challenges
5.1.4.1. Product Recall
5.2. Cumulative Impact of COVID-19
6. Resorbable Vascular Scaffold Market, by Material Type
6.1. Introduction
6.2. Metal Based Bvs
6.3. Polymer Based Bvs
7. Resorbable Vascular Scaffold Market, by Application
7.1. Introduction
7.2. Coronary Artery Stents
7.3. Peripheral Artery Stents
8. Resorbable Vascular Scaffold Market, by End-user
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Cardiac Centers
8.4. Hospitals
9. Americas Resorbable Vascular Scaffold Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Resorbable Vascular Scaffold Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Resorbable Vascular Scaffold Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 480 Biomedical Inc
13.2. Abbott Laboratories
13.3. Amaranth Medical, Inc.
13.4. Amg International
13.5. Arterial Remodeling Technologies
13.6. Biosensors International Group, Limited
13.7. Biotronik Se & Co. Kg
13.8. Boston Scientific Corporation
13.9. Cardionovum GmbH
13.10. Elixir Medical Corporation
13.11. Kyoto Medical Planning Co., Ltd.
13.12. Lepu Medical Technology Co., Ltd.
13.13. Medtronic plc
13.14. Meril Life Sciences Pvt. Ltd.
13.15. Orbusneich
13.16. Qualimed
13.17. Reva Medical, Inc.
13.18. S3V Vascular Technologies Private Limited
13.19. Stentys Sa
13.20. Svelte Medical Systems, Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET DYNAMICS
FIGURE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2027
FIGURE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2027
FIGURE 18. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 23. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2027
FIGURE 25. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 33. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2027
FIGURE 35. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 41. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2027
FIGURE 43. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 45. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2027
FIGURE 47. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2027
FIGURE 62. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 74. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 28. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 29. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 31. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 34. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 36. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 48. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 50. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 51. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 52. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 54. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 55. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 56. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 58. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 59. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 60. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 62. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 63. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 67. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 72. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 74. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 76. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 77. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 78. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 80. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 81. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 82. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 84. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 85. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 86. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 88. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 89. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 90. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 92. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 93. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 94. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 96. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 97. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 98. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 100. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 101. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 102. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 104. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 105. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 106. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 108. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 109. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 110. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 112. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 113. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 114. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 116. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 117. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 123. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 125. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 126. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 127. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 129. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 130. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 131. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 132. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 133. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 134. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 135. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 137. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 138. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 139. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 140. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 141. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 142. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 143. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 145. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 146. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 147. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 149. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 150. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 151. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 152. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 153. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 154. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 155. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 156. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 157. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 158. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 163. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 164. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2019-2027 (USD MILLION)
TABLE 165. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 166. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 167. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 168. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 169. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 170. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET RANKING
TABLE 171. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2021
TABLE 172. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET MERGER & ACQUISITION
TABLE 173. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 174. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 175. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET INVESTMENT & FUNDING
TABLE 176. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 177. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: LICENSE & PRICING

Companies Mentioned

  • 480 Biomedical Inc
  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • AMG International
  • Arterial Remodeling Technologies
  • Biosensors International Group, Limited
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • LEPU medical technology co., ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • OrbusNeich
  • Qualimed
  • REVA Medical, Inc.
  • S3V Vascular Technologies Private Limited
  • Stentys SA
  • Svelte Medical Systems, Inc.

Methodology

Loading
LOADING...